Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Korczynski Sherry
Chief Commercial Officer at Aquestive Therapeutics. Filing since 10 Mar 2026.
CIK 0002026090
Company
Date
Role
Action
Shares
Amount
Of holding
AQST
Aquestive Therapeutics, Inc.
9 Sep 2026
Chief Commercial Officer
Sold on a plan
8,750
$45.68K
3.6%
AQST
Aquestive Therapeutics, Inc.
10 Mar 2026
Chief Commercial Officer
Sold at will
15,741
$65.69K
6.1%
2 decisions on file.
